| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 5e-05 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-05 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.12 | 7e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.13 | 8e-05 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |